Clinical Trial Update: Lenalidomide in Patients With Chronic Myelomonocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates ongoing Phase 1 and Phase 2 evaluation of lenalidomide in chronic myelomonocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelomonocytic Leukemia

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: Chronic Myelomonocytic Leukemia | Phase 1, Phase 2 | Status: UNKNOWN